IQVIA Holdings Inc. logo

IQVIA Holdings Inc. (IQV)

Health Care
$266.90
▼ -1.53%

3 articles

Price chart

+30.9%Jul 20 – Oct 16
$199$237$275Jul 20Aug 18Sep 17Oct 16
Hover the chart for daily prices

Why is IQV moving today?

-1.5%

IQV is -1.5% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.

What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.

Source: Yahoo Finance - quote as of 2 days ago

IQVIA Holdings Inc. (IQV) overview

IQVIA provides clinical-research services and healthcare data analytics.

IQV is a member of the S&P 500. It sits in the Health Care sector. That sector covers pharmaceutical, biotech, device and managed-care companies.

IQVIA Holdings Inc. trades on the NYSE under the ticker symbol IQV. The most recent market data puts the share price at about $266.90. That is down 1.53% on the session. At that price the company is worth roughly $43.93B.

Over the past 52 weeks, IQV has traded between $154.50 and $277.40. Shares change hands at a trailing price-to-earnings (P/E) ratio of about 33.2. The P/E ratio sets the share price against a year of earnings. A higher number means the market is paying more for each dollar the company earns.

Key statistics

Price
$266.90
Change (1d)
-1.53%
Market cap
$43.93B
P/E ratio
33.2
52-week range
$154.50 – $277.40
Day range
$263.21 – $272.98
Volume
1.0M

Source: Yahoo Finance - quote as of 2 days ago

Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.

Why investors watch IQV

IQV is one of the larger names in the Health Care sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each IQV story as it breaks, and tags it bullish, bearish or neutral.

What moves IQV

  • Earnings. IQV reports results four times a year. A surprise against the estimate tends to move the stock that day.
  • Analyst calls. Upgrades, downgrades and new price targets change what the market expects from IQV.
  • Sector news. Health Care stocks often move together, so a rival's news can move IQV too.

Market Mood

1 Bullish2 Neutral0 Bearish

Latest IQV news

IQVIA Holdings Stock Hits 52-Week High at 271.82 USD
MarketsBullish9/15/2026

IQVIA Holdings Stock Hits 52-Week High at 271.82 USD

IQVIA Holdings (IQV) shares reached a 52-week high of 271.82 USD. This milestone reflects strong investor interest and positive market sentiment. The stock's performance could encourage further investments in the healthcare analytics sector. For ordinary investors, the increase in IQV's stock price could signal potential growth opportunities in the biotech and healthcare market.

Read More: IQVIA Holdings Stock Hits 52-Week High at 271.82 USD
IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B
MarketsNeutral8/2/2026

IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B

Ari Bousbib, Chairman and CEO of IQVIA Holdings Inc. (NYSE:IQV), sold about 106,000 shares for proceeds of $26.1 million, according to an SEC Form 4 filing. The shares were sold at a weighted average price of $245.51, slightly below the market close of $247.56 on July 29, 2026. This transaction reduced Bousbib's direct holdings by 11%, but he retains beneficial ownership of 1.4 million shares, including 543,000 shares through the Orohena Trust. This insider sale comes as IQVIA reported record bookings of $3.15 billion, highlighting its robust position in the life sciences industry.

Read More: IQVIA (IQV) CEO Sold $26.1 Million Shares as Bookings Hit $3.15B
IQVIA (IQV) Launches AI Platform to Improve Life Sciences Operations
TechNeutral4/5/2026

IQVIA (IQV) Launches AI Platform to Improve Life Sciences Operations

On March 16, IQVIA Holdings Inc. (IQV) announced the launch of the IQVIA.ai platform, developed in collaboration with Nvidia. The platform aims to enhance operational efficiency in life sciences by integrating healthcare-grade AI with Nvidia's technology. At launch, 19 of the top 20 pharmaceutical companies were reported to be incorporating IQVIA's intelligent agents into their operations. Further enhancements and additional agents are scheduled for release in Q4 2026, indicating the company's commitment to expanding its capabilities in the healthcare space.

Read More: IQVIA (IQV) Launches AI Platform to Improve Life Sciences Operations

More Health Care stocks

Frequently asked questions

Is IQVIA Holdings Inc. in the S&P 500?

Yes. IQVIA Holdings Inc. trades as IQV and is a member of the S&P 500. The index lists it in the Health Care sector.

What sector is IQV in?

IQV sits in the Health Care sector of the S&P 500.

Where can I find the latest IQV news?

Right here. This page collects recent IQV news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.

What is IQVIA Holdings Inc.'s stock price?

IQV last traded at about $266.90. Prices move all through the session, so this is the latest quote rather than a live one.

What is IQVIA Holdings Inc.'s market cap?

IQV is worth roughly $43.93B. Market cap is the share price times the number of shares outstanding.

What is IQV's P/E ratio?

IQV trades at a trailing P/E ratio of about 33.2. The ratio compares the share price with earnings per share over the past year.

New to investing?

© 2026 NewsStocks.liveTermsPrivacy